...
首页> 外文期刊>Journal of industrial and engineering chemistry >ABri peptide aggregation quantification by fluorescamine and alpha imager assay
【24h】

ABri peptide aggregation quantification by fluorescamine and alpha imager assay

机译:通过荧光胺和α成像仪分析定量ABri肽聚集

获取原文
获取原文并翻译 | 示例
           

摘要

Familial British Dementia (FBD) is the early-onset autosomal dominant disorders characterized by cognitive impairment. The ABri is a 34-mer peptide which is the main component of amyloid deposits in FBD. As a first step toward shedding light for the discovery of amyloid inhibition drugs for FBD, we set the optimal conditions for quantification ABri peptide by the fluorescamine and alpha imager assay, which can provide a precise peptide quantity for determination of amyloid inhibition rate at micromolecular level and estimate aggregation rate by measuring monomer and dimer quantity which are filtered through 10,000 Da MW cutoff filter.
机译:家族性英国痴呆症(FBD)是一种以认知障碍为特征的早期发作的常染色体显性遗传疾病。 ABri是一种34-mer肽,是FBD中淀粉样蛋白沉积的主要成分。作为探索FBD淀粉样蛋白抑制药物的第一步,我们设置了通过荧光胺和α成像仪测定定量ABri肽的最佳条件,该条件可以为确定微分子水平的淀粉样蛋白抑制率提供精确的肽量并通过测量通过10,000 Da MW截止过滤器过滤的单体和二聚体数量来估算聚集速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号